-
-
-
-
-
-
-
Regeneron Pharma (REGN) Could Be Seeing 'Peak Enthusiasm' for COVID Opportunity - Baird
-
-
-
-
-
-
-
Gilead Sciences (GILD) Remdesivir China Results 'Very Sobering' - Baird
-
-
-
-
-
-
-
Gilead Sciences (GILD) PT Lowered to $79 at Baird
-
-
-
-
-
-
-
Gilead Sciences (GILD): Quiet 1Q17 Earnings - Baird
-
-
-
-
-
-
-
Intercept (ICPT) AdCom Couldn't Have Gone Better, Baird Says; Notes Gilead (GILD) Exec in the Audience
-
-
-
-
-
-
-
Gilead Sciences (GILD) Bullish Stance Reiterated at Baird on 'Beat and Raise' Q1
-
-
-
-
-
-
-
Gilead Sciences (GILD) Sell-Off is an Overreaction, Baird Said; Doesn't See All Out Price War
-
28,071 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

